Form 4: Electromed Director Sells Shares

Electromed, Inc. Director Kathleen Skarvan reported transactions involving the sale of common stock and the acquisition of employee stock options.

Summary

• Director Kathleen Skarvan acquired 40,000 shares of common stock through a vested employee stock option at a price of $3.82 per share.
• Skarvan also sold a total of 36,438 shares of common stock in multiple transactions on May 15, 2026, with weighted average prices ranging from $34.36 to $36.25 per share.
• Following these transactions, Skarvan beneficially owns 35,622 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents routine insider transactions involving both the acquisition of options and the sale of shares, without clear indicators of significant positive or negative sentiment towards the company's future.

Positives

• Acquisition of 40,000 vested employee stock options at a favorable price of $3.82.
• Director maintains a significant beneficial ownership of 35,622 shares after the reported sales.

Negatives

• Sale of a substantial number of shares (36,438) by a director.
• The sales occurred at prices significantly higher than the exercise price of the acquired options.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the buying and selling activities of company directors and officers. These transactions can sometimes signal insider confidence or a need for liquidity.

Stakeholder Impact

• Shareholders may observe the director's stock sales, which could be interpreted in various ways, though the acquisition of options at a lower price suggests a potential long-term interest.

Key Dates

Keywords

Electromed, ELMD, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Director Transactions, Securities Exchange Act